CRITICAL REVIEWS IN BIOTECHNOLOGY, published by Taylor & Francis Ltd, stands as a leading journal in the field of biotechnology, consistently recognized for its rigorous peer-reviewed articles that impact the disciplines of Applied Microbiology, Biotechnology, and Medicine. With an impressive Q1 ranking in these categories and a significant influence reflected in its Scopus rankings—placing it within the top 5% of Applied Microbiology and the top 4% of Biotechnology journals—the journal serves as an essential resource for researchers, professionals, and students alike. Launched in 1983 and extending its coverage to encompass groundbreaking findings through 2024, it provides a rich forum for insightful reviews and innovative research that propel the field forward. Though not an Open Access journal, CRITICAL REVIEWS IN BIOTECHNOLOGY remains a vital point of reference for ongoing developments, critical analyses, and emerging trends, making it indispensable for those seeking to stay at the forefront of biotechnological advancements.

BioTech is a forward-thinking academic journal published by MDPI, specializing in the dynamic fields of applied microbiology, biotechnology, biochemistry, bioengineering, and biomedical engineering. Established for promoting impactful research from 2021 to 2024, this journal aims to bridge the gap between laboratory findings and practical applications, serving as a vital resource for researchers, practitioners, and students alike. With its Open Access model, BioTech ensures that groundbreaking innovations are freely available to the global community, fostering collaboration and knowledge transfer across disciplines. In the 2023 rankings, BioTech holds a strong position in Q2 and Q3 quartiles across various categories, reflecting its commitment to high-quality research output. Being indexed in renowned databases, the journal enhances its visibility and reach, making it a preferred platform for sharing transformative ideas and discoveries in biotechnology and related domains. Set against the backdrop of Switzerland’s thriving research environment, BioTech is poised to become an essential resource in the rapidly evolving landscape of life sciences.

BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, published by the Korean Society for Biotechnology and Bioengineering, is a prominent journal in the fields of applied microbiology, biotechnology, bioengineering, and biomedical engineering. Since its inception in 1996, this journal has served as a vital platform for researchers and professionals, facilitating the dissemination of cutting-edge research and innovative applications related to bioprocesses and biotechnology systems. With an ISSN of 1226-8372, this journal is ranked within the Q3 quartile across several categories, demonstrating its relevance and impact in the academic community. Although it operates under traditional access modalities, the journal strives to provide quality and timely insights into the advancements in bioprocess technology and microbial applications, fostering a collaborative environment for knowledge exchange. Notably, it is indexed with a respectable presence on Scopus, making it a valuable resource for students and professionals seeking the latest developments in biotechnology. For more details, kindly refer to the Korean Science Technology Center, #704 Yeoksam-Dong, Gangnam-Ku, Seoul 135-703, South Korea.

JOURNAL OF BIOTECHNOLOGY, published by Elsevier, stands as a premier platform in the fields of Applied Microbiology, Biotechnology, Bioengineering, and Medicine. With an ISSN of 0168-1656 and an E-ISSN of 1873-4863, this journal has significantly contributed to the advancement of biotechnological research since its inception in 1984 and continues to be a vital resource until 2024. Notably ranked in the Q2 quartile across multiple categories, it excels with impressive Scopus rankings, placing within the top 20% in Applied Microbiology and Biotechnology. This underscores its impact on both the scientific community and the ongoing developments in biotechnological applications. The journal encourages submissions that promote innovative research and practical insights, fostering collaboration among researchers, professionals, and students alike. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and commitment to excellence in biotechnological literature.

MOLECULAR BIOTECHNOLOGY, published by SPRINGERNATURE, is a pivotal journal in the fields of applied microbiology, molecular biology, biochemistry, and biotechnology. Since its inception in 1994, the journal has aimed to disseminate high-quality research that explores the intersection of molecular biology and technology, fostering advancements in biotechnology applications. With an ISSN of 1073-6085 and an E-ISSN of 1559-0305, it has established itself as a significant contributor to the scientific community, currently holding a Q3 ranking across multiple categories including Applied Microbiology & Biotechnology and Biochemistry in the 2023 metrics. Although not an open access publication, the journal remains accessible through various institutional subscriptions, providing valuable insights and findings to researchers and professionals. Given its ongoing commitment to quality and relevance, MOLECULAR BIOTECHNOLOGY serves as an essential resource for those involved in cutting-edge research and innovation in molecular biotechnology and related disciplines.

Journal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.

Industrial Biotechnology, published by Mary Ann Liebert, Inc., is a premier journal dedicated to the rapidly evolving field of biotechnology with a particular focus on its applications in industrial settings. Since its inception in 2006, this influential journal has been a vital resource for researchers and professionals keen on exploring innovative bioprocesses and the sustainable use of biological systems in industry. With an ISSN of 1550-9087 and an E-ISSN of 1931-8421, Industrial Biotechnology maintains a Q3 ranking in the biotechnology category, ranking 216 out of 311 in Scopus, signifying its growing impact in the field despite a current percentile rank of 30. This journal collects and disseminates significant findings that bridge the gap between science and technology, emphasizing ecological sustainability and economic viability in industrial practices. While offering traditional subscription options, it connects readers with cutting-edge advancements that shape modern biotechnology. As you delve into the pages of Industrial Biotechnology, expect to uncover groundbreaking research and pivotal insights that foster the advancement of this vital discipline.

BIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.

Synthetic and Systems Biotechnology, published by KEAI PUBLISHING LTD, is a pioneering open-access journal that has made significant contributions to the fields of applied microbiology, biotechnology, biomedical engineering, genetics, and structural biology since its inception in 2016. With an ISSN of 2405-805X, this journal is committed to fostering innovative research and interdisciplinary collaboration, providing a platform for the dissemination of high-quality studies that push the boundaries of scientific knowledge. Recognized for its excellence, it holds prestigious Q1 rankings in both Applied Microbiology and Biotechnology as well as Biomedical Engineering in 2023, alongside notable Q2 rankings in Genetics and Structural Biology. Researchers, professionals, and students alike can access cutting-edge research that explores the dynamic interplay between synthetic biology and systems biology, driving advancements that could reshape health, industry, and environmental sustainability. By operating under an open-access model, Synthetic and Systems Biotechnology ensures that new findings are accessible to a global audience, thereby maximizing the impact and reach of the published work and paving the way for future discoveries.

3 Biotech is a prestigious interdisciplinary journal, published by SPRINGER HEIDELBERG, focusing on the evolving fields of biotechnology, agricultural and biological sciences, and environmental science. With an impressive impact factor and categorized in Q2 across multiple fields in the 2023 rankings, this journal stands out for its contribution to innovative research and its commitment to advancing scientific understanding. Featuring rigorous peer-reviewed articles, it serves as a vital resource for researchers, professionals, and students alike, further enhanced by its significant presence in Scopus rankings. This journal facilitates open discussions and collaborative efforts, aiming to bridge the gap between theoretical research and practical applications in biotechnology. As it continues to publish impactful studies from 2011 to 2024, 3 Biotech is dedicated to shaping the future of biosciences and fostering meaningful scientific advancements.